Bouchez, Clémentine
Pluvy, Johan
Soussi, Ghassen
Nguenang, Marina
Brosseau, Solenn
Tourne, Morgan
Collin, Mégane
Théou-Anton, Nathalie
Guyard, Alice
Ammar, Jamila
Khalil, Antoine
Zalcman, Gérard
Gounant, Valérie
Article History
Received: 25 July 2020
Accepted: 12 November 2020
First Online: 3 December 2020
Ethics approval and consent to participate
: According to the French regulation for observational retrospective studies, all patients received the printed institutional information sheet stating their pseudonymised personal clinical, biological and evolution data could be analyzed for medical and epidemiological studies, but that they keep the possibility to oppose to the utilization of such data. The computed patient study file was registered at the National Commission for Computing Liberties (CNIL registration number #2,161,770), with the study approved by the Institutional Review Board of the French-Learned Society for Respiratory Medicine (Société de Pneumologie de Langue Française) (CEPRO number #2020–010).
: Written informed consent for publication was obtained from Patient 1. The others patients died and their cases are not detailed.
: CB, GS, MN, MT, MC, NT-A, AG, JA, AK declare that they have no competing interests.JP reports personal fees from Astra Zeneca, BMS and MSD, outside the submitted work.SB reports personal fees from BMS, Roche and Chugai, outside the submitted work.GZ reports personal fees from BMS, MSD, Borhinger, non-financial support and other from Roche, non-financial support and other from Astra-Zeneca, other from Abbvie, outside the submitted work.VG reports personal fees from MSD, Chugai, Novartis, Borhinger, personal fees and non-financial support from Astra Zeneca, BMS, Takeda, Pfizer, grants, personal fees and non-financial support from Roche, outside the submitted work.